Modulation of CYP3A4 expression by ceramide in human colon carcinoma HT-29 cells

By Chun Y-J.   Lee S.   Ae Yang S.   Park S.   Young Kim M.  

Biochemical and Biophysical Research Communications, Vol. 298, Iss. 5, 2002-11 ,pp. : 687-692

Elsevier

Access to resources Recommend Favorite

Retinoic Acid Receptor α Mediates Growth Inhibition by Retinoids in Human Colon Carcinoma HT29 Cells

By Nicke B.   Kaiser A.   Wiedenmann B.   Riecken E-O.   Rosewicz S.  

Biochemical and Biophysical Research Communications, Vol. 261, Iss. 3, 1999-08 ,pp. : 572-577

Elsevier

Access to resources Recommend Favorite

Characterization of Galactosyl Glycerolipids in the HT29 Human Colon Carcinoma Cell Line

By Påhlsson P.   Spitalnik S.L.   Spitalnik P.F.   Fantini J.   Rakotonirainy O.   Ghardashkhani S.   Lindberg J.   Konradsson P.   Larson G.  

Archives of Biochemistry and Biophysics, Vol. 396, Iss. 2, 2001-12 ,pp. : 187-198

Elsevier

Access to resources Recommend Favorite

Pretreatment by Tubulin Agents Decreases C-MYC Induction in Human Colon Carcinoma Cell Line HT29-D4

By El Khyari S.   Bourgarel V.   Barra Y.   Braguer D.   Briand C.  

Biochemical and Biophysical Research Communications, Vol. 231, Iss. 3, 1997-02 ,pp. : 751-754

Elsevier

Access to resources Recommend Favorite

Oroxylin A improves the sensitivity of HT-29 human colon cancer cells to 5-FU through modulation of the COX-2 signaling pathway

By Ha Jun   Zhao Li   Zhao Qing   Yao Jing   Zhu Bin-Bin   Lu Na   Ke Xue   Yang Hui-Ying   Li Zhiyu   You Qi-Dong   Guo Qing-Long  

Biochemistry and Cell Biology, Vol. 90, Iss. 4, 2012-08 ,pp. : 521-531

NRC Research Press

Access to resources Recommend Favorite